{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-016422","form_type":"8-K","ticker":"ELMD","cik":"0001488917","company_name":"Electromed, Inc.","filed_at":"2026-05-12T20:06:45+00:00","discovered_at":"2026-05-12T20:08:00.302384+00:00","generated_at":"2026-05-12T21:28:27.496980+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Electromed posts record Q3 FY2026 revenue $18.6M (+18% YoY); EPS $0.35 (+59%)","bullets":["Net revenue $18.6M (+18.4% YoY); homecare revenue $16.7M (+18.6%) driven by 57 direct sales reps.","Operating income $3.8M (+76.0% YoY, 20.3% of revenue); net income $3.0M, $0.35 diluted EPS.","Cash $17.0M, no debt; working capital $40.0M; shareholders' equity $49.2M.","14th consecutive quarter of YoY revenue and profit growth; 86% of covered lives under contract."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-016422","json":"https://secwatch.observer/filing/0001437749-26-016422.json","markdown":"https://secwatch.observer/filing/0001437749-26-016422.md","text":"https://secwatch.observer/filing/0001437749-26-016422.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1488917/000143774926016422/0001437749-26-016422-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1488917/000143774926016422/elmd20260213_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-12T21:28:27.496980+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4f7549352de9609c3fa84b7ac8d9ac10344a357c","claim":"Electromed, Inc. reported the three months ended March 31, 2026 results: revenue $ 18.6 million, net income $ 3.0 million, or $ 0.35 per diluted share, EPS $ 0.35 per diluted share.","evidence_excerpt":"today announced financial results for the three and nine months ended March 31, 2026 (“ Q3 FY 2026 ”). Q3 FY 2026 Company Highlights ● Net revenues increased 18.4% to a record $ 18.6 million in Q3 FY 2026, from $ 15.7 million in the third quarter of the prior fiscal year, led by an 18.6% increase in the core homecare market. ● Operating income increased to a record $","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1488917/000143774926016422/0001437749-26-016422-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended March 31, 2026"},{"label":"Revenue","value":"$ 18.6 million"},{"label":"Net income","value":"$ 3.0 million, or $ 0.35 per diluted share"},{"label":"EPS","value":"$ 0.35 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}